← Back to headlines
GLP-1 Drugs Face Inequality Challenges in Addressing US Obesity Crisis
GLP-1 drugs are being hailed as a potential 'game-changer' for America's obesity crisis, but their widespread impact is hindered by two significant inequalities. These disparities limit access and effectiveness for many who could benefit.
20 Aug, 13:00 — 20 Aug, 13:00
Sources
Showing 1 of 1 sources
